Latest Financial Performance News

Page 97 of 224
AUB Group has reported a robust FY25 with a 17% rise in underlying net profit after tax and increased dividends, setting an optimistic tone for FY26 with growth guidance up to 13.4%.
Claire Turing
Claire Turing
26 Aug 2025
AUB Group Limited has reported a robust FY25 financial performance, highlighted by a 171% increase in underlying net profit after tax and a 15.2% rise in total dividends. Strategic acquisitions and organic growth across divisions underpin the company’s strong momentum.
Claire Turing
Claire Turing
26 Aug 2025
NZME Limited reported a 3.1% revenue decline for H1 2025 but delivered a 12% rise in operating EBITDA, driven by digital growth and cost efficiencies. The company declared a 3 cent interim dividend amid ongoing economic challenges.
Elise Vega
Elise Vega
26 Aug 2025
Genesis Energy reported a robust FY25 with a 14% rise in normalised EBITDAF and a 29% jump in net profit, driven by strategic portfolio flexibility amid volatile energy markets. The company accelerated its Gen35 strategy, including key renewable projects and long-term capacity contracts to bolster New Zealand’s energy security.
Maxwell Dee
Maxwell Dee
26 Aug 2025
Metals X Limited reported a robust half-year to June 2025 with profit after tax soaring 256% to $52.9 million, driven by higher tin sales and prices from its Renison joint venture. The company also progressed key projects and deepened strategic investments while reinforcing its ESG and safety frameworks.
Maxwell Dee
Maxwell Dee
25 Aug 2025
Acrow Limited reports a record FY25 with sales up 23%, driven by an 83% jump in its Industrial Access division, now half of group revenue. Despite soft formwork markets, strategic acquisitions and growth initiatives underpin a confident outlook.
Victor Sage
Victor Sage
25 Aug 2025
Acrow Limited reported a 23% revenue increase to $265.1 million for FY25, driven by strong growth in its Industrial Access division and key acquisitions. Despite a slight dip in earnings per share, the company declared a fully franked final dividend of 2.95 cents per share.
Victor Sage
Victor Sage
25 Aug 2025
Actinogen Medical reported a $14.7 million net loss for FY25 while progressing its lead drug Xanamem through pivotal Alzheimer’s and depression trials, with interim results expected in January 2026. The company has secured funding through mid-2026 and is preparing for commercialization.
Ada Torres
Ada Torres
25 Aug 2025
Supply Network Limited reported a robust 15.5% revenue increase to $349.9 million and a 21.2% rise in profit after tax to $40 million for FY2025, alongside a higher fully franked final dividend of 38 cents per share.
Victor Sage
Victor Sage
25 Aug 2025
Symal Group Limited reported a robust FY25 with revenue and earnings growth exceeding Prospectus forecasts, underpinned by strategic acquisitions and a strong pipeline of contracts.
Victor Sage
Victor Sage
25 Aug 2025
Symal Group has outperformed its FY25 earnings forecasts, driven by strong project margins and strategic acquisitions, setting a robust foundation for FY26 growth.
Victor Sage
Victor Sage
25 Aug 2025
Symal Group Limited reports a strong first year as an ASX-listed company, exceeding earnings forecasts and advancing its growth through key acquisitions and sustainability initiatives.
Victor Sage
Victor Sage
25 Aug 2025